These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22198561)

  • 21. Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspective.
    Ando Y; Hamasaki T
    Pharm Stat; 2010; 9(3):190-200. PubMed ID: 20737442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches.
    Coecke S; Pelkonen O; Leite SB; Bernauer U; Bessems JG; Bois FY; Gundert-Remy U; Loizou G; Testai E; Zaldívar JM
    Toxicol In Vitro; 2013 Aug; 27(5):1570-7. PubMed ID: 22771339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interpretation and considerations on the safety evaluation of human drug metabolites.
    Atrakchi AH
    Chem Res Toxicol; 2009 Jul; 22(7):1217-20. PubMed ID: 19563206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The non-GLP toleration/dose range finding study: design and methodology used in an early toxicology screening program.
    Herlich JA; Taggart P; Proctor J; Stahle P; Colis R; Hall L; Pugsley MK
    Proc West Pharmacol Soc; 2009; 52():94-8. PubMed ID: 22128433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of non-linear (dose-dependent) pharmacokinetics in hazard assessment.
    Watanabe PG; Young JD; Gehring PJ
    J Environ Pathol Toxicol; 1977; 1(2):147-59. PubMed ID: 553128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
    Robinson S; Delongeas JL; Donald E; Dreher D; Festag M; Kervyn S; Lampo A; Nahas K; Nogues V; Ockert D; Quinn K; Old S; Pickersgill N; Somers K; Stark C; Stei P; Waterson L; Chapman K
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):345-52. PubMed ID: 18295384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose selection for toxicity studies: a protocol for determining the maximum repeatable dose.
    Spurling NW; Carey PF
    Hum Exp Toxicol; 1992 Nov; 11(6):449-57. PubMed ID: 1361132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing environmental toxicology through chemical dosimetry: external exposures versus tissue residues.
    McCarty LS; Landrum PF; Luoma SN; Meador JP; Merten AA; Shephard BK; van Wezel AP
    Integr Environ Assess Manag; 2011 Jan; 7(1):7-27. PubMed ID: 21184567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.
    Tan YM; Barton HA; Boobis A; Brunner R; Clewell H; Cope R; Dawson J; Domoradzki J; Egeghy P; Gulati P; Ingle B; Kleinstreuer N; Lowe K; Lowit A; Mendez E; Miller D; Minucci J; Nguyen J; Paini A; Perron M; Phillips K; Qian H; Ramanarayanan T; Sewell F; Villanueva P; Wambaugh J; Embry M
    Regul Toxicol Pharmacol; 2021 Dec; 127():105070. PubMed ID: 34718074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Background to the ADI/TDI/PTWI.
    Herrman JL; Younes M
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.